A complication of preterm birth is underdeveloped lungs that lack surfactant and adequate gas exchange due to immature alveoli. Although recent advances have been made, the process of alveolar maturation is not well understood. A goal of this project is to understand signaling from mesenchymal cells that direct alveologenesis, the final stage of lung development. We have found that disruption of a specialized fibroblast, the lipofibroblast, results in reduced type II alveolar cell differentiation. Type II alveolar cells are responsible for surfactant production, and we will investigate the communication between lipofibroblasts and alveolar cells during lung development in the mouse. The lipofibroblast has been a difficult cell to identify, and little is known about the function of these cells. Our preliminary data demonstrate that a transcription factor is required for the development of lipofibroblasts and alveolar differentiation. Based upon these preliminary findings, we hypothesize that lipofibroblasts are required for the later steps of lung development and that they secrete growth factors that are required specifically for terminal differentiation of type II alveolar cells. We will investigate these cellular interactions in two specific aims.
In specific aim I, we will determine how lipofibroblasts impact alveolar differentiation by examining the temporal requirement for lipofibroblasts and by evaluating postnatal lung development in mice lacking lipofibroblasts.
In Specific Aim II we will use in vitro organoid culture and gene expression profiling to explore the lipofibroblast cellular signals that direct type II alveolar differentiation. Together these aims will define the role of the lipofibroblast and potentially identify therapeutic targets for increasing the rate of type II alveolar differentiation in preterm births.

Public Health Relevance

One complication of premature birth is airway collapse, known as respiratory distress syndrome. This condition is cause by underdeveloped alveoli, and the goal of this project is to better understand the cellular signals that guide postnatal lung development. Information gained in these studies may lead to improved treatments for lung maturation and reduce the amount of time that infants spend on ventilators.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21HL156112-01
Application #
10111423
Study Section
Lung Injury, Repair, and Remodeling Study Section (LIRR)
Program Officer
Lin, Sara
Project Start
2021-02-01
Project End
2023-01-31
Budget Start
2021-02-01
Budget End
2022-01-31
Support Year
1
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of Hawaii
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
965088057
City
Honolulu
State
HI
Country
United States
Zip Code
96822